Skip to content

Clinical trials

Dyspnea trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspnea Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20131
20151
20161
20171
20181
20201
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangzhou Institute of Respiratory Disease4
Novartis Pharmaceuticals2
Medtronic Cardiac Rhythm and Heart Failure1
Nanfang Hospital, Southern Medical University1
Pfizer1
Scios, Inc.1
The University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspnea11
Asthma3
Heart Failure2
Pulmonary Disease, Chronic Obstructive2
Airway Obstruction1
COVID-191
Cardiomyopathies1
Coronavirus Infections1
Cough1
Disease1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.